Category Archives: vaccines

 

BiondVax to Raise $10 M on NASDAQ

BiondVax Pharmaceuticals Ltd. (TASE:BNDX), which is developing a universal vaccine for many types of influenza, announced that it was submitting a prospectus to Nasdaq that will allow it to offer shares through American depositary receipts (ADRs) after the company is listed. BiondVax is seeking to raise up to $10 million...
Read more

Opportunities in Chinese Vaccine Market

The urgent need for improved vaccines in the Chinese market was made clear in recent weeks as the Chinese media reported the tragic news of several babies that died after they received hepatitis B vaccines made by a local manufacturer. There are big opportunities for the developers of improved safe...
Read more

ALS Patient Responds to BrainStorm Stem Cells

Israeli Channel 2 TV interviewed a patient suffering from Myasthenia Gravis (MG) and recently diagnosed with ALS. The patient reported that he has experienced visible improvement in his speech, walking, balance, posture, muscle strength, appetite, digestion, and weight gain following compassionate treatment with BrainStorm’s NurOwn cell therapy. “Due to the...
Read more

BiondVax Plans Phase II Flu Vaccine

BiondVax Pharmaceuticals has announced plans to start a second Phase II trial for the development of a product that is intended to enhance the effectiveness of existing flu vaccines. That product aims to be the forerunner of the company`s ultimate goal – the development of a universal flu vaccine. The...
Read more